Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Karyopharm Therapeutics (KPTI)
NASDAQ:KPTI
RESEARCH TOOLSreports
Holding KPTI?
Track your performance easily
Karyopharm Therapeutics (KPTI) Ownership Overview
2.34% Insiders
9.64% Mutual Funds
20.26% Other Institutional Investors
7.74% ETFs
60.03% Public Companies and
Individual Investors
The ownership structure of Karyopharm Therapeutics (KPTI) stock is a mix of institutional, retail, and individual investors. Approximately 37.64% of the company’s stock is owned by Institutional Investors, 2.34% is owned by Insiders, and 60.03% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 07, 2024 | Deepika Pakianathan Director | xxxxxxxxxxxxx | $780695 |
| Jun 04, 2024 | Deepika Pakianathan Director | xxxxxxxxxxxxx | $878906 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,064,504 | Institution | 4.04% | 4,021,216 | |
| 5,064,504 | Institution | 4.04% | 4,021,216 | |
| 3,806,331 | Institution | 3.04% | 3,022,227 | |
| 2,008,163 | Institution | 1.60% | 1,594,481 | |
| 1,149,677 | Institution | 0.92% | 912,844 | |
| 1,131,932 | Insider | 0.90% | 898,754 | |
| 1,125,000 | Institution | 0.90% | 893,250 | |
| 702,009 | Institution | 0.56% | 557,395 | |
| 500,000 | Institution | 0.40% | 397,000 | |
| 404,051 | Insider | 0.32% | 320,816 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,064,504 | Institution | 4.04% | 4,021,216 | |
| 2,008,163 | Institution | 1.60% | 1,594,481 | |
| 1,149,677 | Institution | 0.92% | 912,844 | |
| 1,125,000 | Institution | 0.90% | 893,250 | |
| 702,009 | Institution | 0.56% | 557,395 | |
| 500,000 | Institution | 0.40% | 397,000 | |
| 402,887 | Institution | 0.32% | 319,892 | |
| 264,500 | Institution | 0.21% | 210,013 | |
| 186,000 | Institution | 0.15% | 147,684 | |
| 169,383 | Institution | 0.14% | 134,490 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,421,515 | Institution | 2.73% | 2,839,857 | |
| 1,642,989 | Institution | 1.31% | 1,363,681 | |
| 712,696 | Institution | 0.57% | 596,740 | |
| 712,696 | Institution | 0.57% | 596,740 | |
| 712,696 | Institution | 0.57% | 596,740 | |
| 556,081 | Institution | 0.44% | 465,607 | |
| 556,081 | Institution | 0.44% | 465,607 | |
| 289,443 | Institution | 0.23% | 242,351 | |
| 262,807 | Institution | 0.21% | 208,800 | |
| 218,791 | Institution | 0.17% | 178,096 |
FAQ
Who Owns Karyopharm Therapeutics (KPTI)?
According to the latest TipRanks data, approximately 20.26% of the company's stock is held by institutional investors, 2.34% is held by insiders, and 60.03% is held by retail investors.
What percentage of Karyopharm Therapeutics (KPTI) stock is held by institutional investors?
According to the latest TipRanks data, approximately 20.26% of Karyopharm Therapeutics (KPTI) stock is held by institutional investors.
What percentage of Karyopharm Therapeutics (KPTI) stock is held by retail investors?
According to the latest TipRanks data, approximately 60.03% of Karyopharm Therapeutics (KPTI) stock is held by retail investors.
Who owns the most shares of Karyopharm Therapeutics (KPTI)?
Vanguard owns the most shares of Karyopharm Therapeutics (KPTI).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.